Effects of intranasal Imunofan administration upon phagocytic activity in treatment of exudative otitis media in children

Exudative otitis  media  in  childhood is most  often  associated with  chronic inflammation in the  nasopharyngeal area,  with  immediate participation of phagocytic cells. Our  paper  presents  the  data  on evaluation of clinical  and immunological efficacy of intranasal Imunofan use included into  complex therapy of exudative  otitis  media.  Dynamic observation (before  treatment, 1 and  3 months after treatment) of these parameters included regular  evaluation of the  neutrophil and  monocyte amounts in peripheral blood  and  in smear imprints from nasal mucosa, determination of myeloperoxidase activity in circulating neutrophils, and the content of interleukin IL-8 and IL-18  in the nasal washouts. The clinical status was assessed using a scoring system, which subjectively reflected the state of the nasopharynx and auditory function. Fourty-three children aged from 3 to 7 years with exudative  otitis media associated with chronic adenoiditis were examined. Patients of the first group (22 children) were treated using only conventional approaches (basic therapy). The patients from  the  second  group  (21 children) received  Imunofan in addition to the  basic therapy. The  control group consisted of 16 relatively  healthy  children. Before  treatment of the  children with exudative  otitis  media, an increase  in the relative content of monocytes in their blood,  a decreased activity of myeloperoxidase and lower concentration of IL-8  and  IL-18  in the  nasal  wash was observed  in comparison with  healthy  controls. No differences in severity  of clinical  symptoms were revealed  between  the  groups  of patients. Baseline  therapy was not  accompanied by positive  dynamics in the  clinical  pattern of the  disease.  Relative  monocytosis and reduced activity of neutrophilic myeloperoxidase persisted  in peripheral blood;  the concentration of IL-8  and IL-18  in the  nasal washings  remained low. Following intranasal use of Imunofan, the  number of circulating monocytes was restored by the  third  month from  the  start  of treatment, there  was an  increased activity  of myeloperoxidase registered  in blood neutrophils, as well as higher IL-8  and IL-18  concentrations in the nasal washings. Normalization of the phagocytos-related parameters, according to this scoring,  was associated with clinical remission of the disease. The revealed relationships between clinical data and the results obtained in the course  of laboratory research  suggest a positive effect of Imunofan as an agent that may enhance effectiveness of conventional basic therapy  of otitis media in children.

1. Diseases of the ear, throat, nose in childhood: national leadership / Ed. M.R. Bogomilsky, V.R. Chistyakova. Moscow: GEOTAR-Media, 2008. 736 p.

2. Zorina V.N., Klimova I.I., Bazhenov D.V., Zorina R.M., Druzhinina Yu.G., Zorin N.A. Features of the immune response in the pathology of the pharyngeal tonsil. Immunologiya = Immunology, 2011, no. 3, pp. 163-165. (In Russ.)

3. Kadagidze Z.G. Cytokines. Prakticheskaya onkologiya = Practical Oncology, 2003, Vol. 4, no. 3, pp. 131-138. (In Russ.)

4. Karaulov A.V. Clinical and immunological efficacy of imunofan for opportunistic infections. Lechashchiy vrach = Attending Physician, 2000, no. 5-6, pp. 28-29.(In Russ.)

5. Karaulov A.V., Sokurenko S.I. Imunofan: immediate and long-term results of treatment of patients with chronic bronchitis. Medikal Market = Medical Market, 2000, no. 34, pp. 21-24. (In Russ.)

6. Kuznetsova R.N., Sysoev K.A., Lebedev V.V., Tutelyan A.V., Totolyan A.A. Features of changes in local immunity in patients with chronic adenoiditis and the possibility of their correction with Imunofan. Meditsinskaya immunologiya = Medical Immunology (Russia), 2008, Vol. 10, no. 6, pp. 551-562. (In Russ.) doi: 10.15789/1563-0625-2008-6-551-562.

7. Kuznetsova R.N., Sysoev K.A., Lebedev V.V., Tutelyan A.V., Totolyan A.A. Cytokines in nasopharyngeal washes of patients with chronic adenoiditis during monotherapy with immunofan. Meditsinskaya immunologiya = Medical Immunology (Russia), 2008, Vol. 10, no. 2-3, pp. 261-268. (In Russ.) doi:10.15789/1563-0625-2008-2-3-261-268.

8. Mayansky D.N. Lectures on clinical immunology: a guide for physicians]. Moscow: GEOTARMedia, 2007. 464 p.

9. Menshikov V.V. Laboratory research methods in the clinic: a handbook. Moscow: Medicine, 1987. 368 p.

10. Popov N.N., Ognivenko E.V. The nature of immune disorders in persons with ENT pathology and methods for their correction. Vestnik KhNU im. V.N. Karazina. Seriya “Meditsina” = Bulletin of V. Karazin Kharkiv National University. Medicine Series, 2010, no. 19 (898), pp. 88-96. (In Russ.)

11. Pleshko R.I., Starokha A.V., Shcherbik N.V., Kologrivova E.N., Iunusov R.Sh., Klimov A.V., Fedorova O.V. The morphofunctional prerequisites for the development of exudative otitis media in the children presenting with chronic adenoiditis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology, 2014, no. 4, pp. 39-41. (In Russ.)

12. Ryazantseva N.V., Novitsky V.V., Zhukova O.B., Urazova O.I., Radzivil T.T., Kulagina I.V., Kovaleva N.P. Modern technologies of laboratory medicine: Textbook. Tomsk: Printed Manufactory, 2008. 360 p.

13. Saidov M.Z., Jamalutdinov Yu.A., Asmailova A.M., Najfiutdinov I.I., Elkun B.B. Assessment of the clinical informativeness of the relationship of indicators of systemic and local humoral immunity in frequently ill children with ENT-organ pathology. Immunologiya = Immunology, 2007, Vol. 28, no. 3, pp. 170-177. (In Russ.)

14. Totolyan A.A., Freidlin I.S. Cells of the immune system. St. Petersburg: Science, 2000. 231 p.

15. Scherbik N.V., Yunusov R.Sh., Starokha A.V., Pleshko R.I., Kologrivova E.N., Litvak M.M., Chichinskas E. Clinical and immunological manifestations of otitis media with otitis media in children on the background of immunocorrection. Omskiy nauchnyy vestnik = Omsk Scientific Bulletin, 2014, Vol. 134, no. 2, pp. 66-69. (In Russ.)

16. Yunusov R.Sh., Pleshko R.I., Scherbik N.V., Kologrivova E.N., Komarova S.V. The role of factors of innate immunity in the development of exudative otitis media in children with hypertrophy of the pharyngeal tonsil. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2013, Vol. 7 (16), no. 2-3, p. 269. (In Russ.)

17. Lin K.M., Austin G.E. Functional activity of three distinct myeloperoxidase (MPO) promoters in human myeloid cells. Leukemia, 2002, Vol. 16, no. 6, pp. 1143-1153.

18. Persson C., Ulle L. Resolution of leucocyte-mediated mucosal diseases.A novel in vivo paradigm for drug development. Br. J. Pharmacol., 2012, Vol. 165, no. 7, pp. 2100-2109.

19. Stol K., Diavatopoulos D.A., Graamans K., Engel A.M., Melchers J.G., Savelkoul F.J., Hays P., Warris M.D., Peter W.M. Inflammation in the middle ear of children with recurrent or chronic otitis media is associated with bacterial load. Pediatr. Inf. Dis. J., 2012, Vol. 31, no. 11, pp. 1228-1134.

20. Türkoğlu Babakurban S., Aydın E. Adenoidectomy: current approaches and review of the literature. Kulak Burun Bogaz Ihtis Derg., 2016, , no. 26 (3), pp. 181-190.

21. Wang W., Wang X., Ward A.C., Touw I.P., and Friedman A.D. C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes. Leukemia, 2001, Vol. 15, no. 5, pp. 779-786.